Delivery Order SPE2DR25D3103-SPE2DR26F9H35
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $10,311.22. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is set to be completed by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,725.94 by the Defense Logistics Agency (DLA) on November 20, 2025, for the supply of Lidocaine 5% Patch 30s. The award is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 21, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively-awarded delivery order on October 21, 2025, by the Defense Logistics Agency to supply Lidocaine 5% Patch 30s with a ceiling value of $3,549.60. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 22, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,131.45. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without any set-aside designation. The award falls under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lidocaine 5% Patch 30-count units, with a ceiling value of $10,834.22 and firm fixed pricing. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $1,429.80 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S, a topical pain management pharmaceutical product. The contract, issued on November 4, 2025, with an ultimate completion date of November 5, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $14,078.17 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $13,932.60 and a firm fixed price structure. The delivery order carries an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units under a firm fixed-price contract valued at $5,633.88. This non-set-aside delivery order is scheduled for completion by November 5, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,256.30 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lidocaine 5% Patch 30S, a topical pain management pharmaceutical. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. The delivery order is a child contract issued under...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9H35Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $11,209.34 by the Defense Logistics Agency (DLA) on November 20, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The contract employs firm fixed-price pricing and carries an ultimate completion date of November 21, 2025. The award was not designated as a set-aside contract, indicating it was competitively awarded through open procurement processes. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's substantial presence in federal medical procurement, combined with its demonstrated capability to meet competitive requirements across multiple therapeutic domains, positions it as a critical vendor for Defense Health Agency and other military healthcare system needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 11/20/25 |